FSNUY Fresenius SE and Company KGaA (PK)

   By Max Bernhard 
 

Fresenius SE (FRE.XE) said Tuesday that second-quarter net profit jumped, and backed its guidance for the full year.

The health-care company said group net profit for the quarter rose 45% to 652 million euros ($761.86 million) from the same period the year before. Group sales declined 2% to EUR8.38 billion from EUR8.53 billion.

Fresenius confirmed 2018 group guidance, forecasting sales to grow by 5% to 8% in constant currency, and net income growth of 6% to 9% in constant currency.

Fresenius Medical Care AG (FME.XE)--the dialysis company majority-owned by Fresenius--reported lower revenue but said net profit rose over the quarter.

It reported second-quarter sales of EUR4.21 billion, down 6%. Net income jumped to EUR994 million from EUR269 million, including gains from the sale of its care coordinations business and the effects of the U.S. tax reform. Excluding those effects, net income grew 6% in constant currency, Fresenius Medical Care said.

Fresenius Medical Care confirmed its 2018 guidance.

Write to Max Bernhard at max.bernhard@dowjones.com; @mxbernhard

(END) Dow Jones Newswires

July 31, 2018 01:49 ET (05:49 GMT)

Fresenius SE and Company... (PK) (USOTC:FSNUY)
Historical Stock Chart
From Jan 2025 to Feb 2025

Fresenius SE and Company... (PK) (USOTC:FSNUY)
Historical Stock Chart
From Feb 2024 to Feb 2025